NCT02578693View on ClinicalTrials.gov

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

CompletedOBSERVATIONAL
Enrollment

1,210

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Chronic Hepatitis C Infection
Trial Locations (3)

100039

Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital, Beijing

00852

Humanity and Health GI and Liver Centre, Hong Kong

400-8506

Yamanashi Prefectural Central Hospital, Kofu

All Listed Sponsors
collaborator

Beijing 302 Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Yamanashi Prefectural Central Hospital

UNKNOWN

lead

Humanity and Health Research Centre

OTHER

NCT02578693 - Follow up of IFN Vs DAAs HCV SVR (IFDACS Study) | Biotech Hunter | Biotech Hunter